4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001828724-26-000003
Options or other derivatives
- Chief Executive Officer acquired 1,075,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GOTTSCHALK ADRIAN · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-05 | Grant or award : show line 1 in the form Stock option (right to buy) | +1,075,000 | $5.23 | $5,622,250 | 1,075,000 | D |
Loading xslF345X05/primarydocument.xml…